OFLX Downgraded to Underperform on Margin Pressure, Weak Cash Flows
Omega Flex's downgrade rating reflects shrinking margins, rising costs and weakening profitability, raising concerns over its near-term growth outlook.
Omega Flex's downgrade rating reflects shrinking margins, rising costs and weakening profitability, raising concerns over its near-term growth outlook.
OFLX reports a year-over-year decline in Q1 earnings per share as rising material costs and higher expenses weigh on margins.
EXTON, Pa., April 29, 2026 (GLOBE NEWSWIRE) -- Dean W. Rivest, CEO, announced that net sales of Omega Flex, Inc. (the “Company”) for the first quarters of 2026 and 2025 were $23,093,000 and $23,330,000, respectively, decreasing $237,000 or 1.0%. Net income for the first quarters of 2026 and 2025 were $2,007,000 and $3,568,000, respectively, decreasing $1,491,000 or 41.8%. The decrease in net income was mainly due to rising raw material costs, including tariffs, marketing efforts, and product enhancement and certification related expenses.
Omega Flex, Inc. (NASDAQ: OFLX - Get Free Report) saw a significant decline in short interest in March. As of March 13th, there was short interest totaling 56,397 shares, a decline of 26.8% from the February 26th total of 77,084 shares. Based on an average daily trading volume, of 61,536 shares, the short-interest ratio is currently
EXTON, Pa., March 25, 2026 (GLOBE NEWSWIRE) -- Omega Flex, Inc. (the “Company”) (NASDAQ: OFLX) today announced that the Board of Directors declared a regular quarterly dividend of $0.34 per share payable on April 21, 2026, to shareholders of record on April 9, 2026. In determining the amount of future regular quarterly dividends, the Board will review the cash needs of the Company, and based on results of operations, financial condition, capital expenditure plans, and consideration of possible acquisitions, as well as such other factors as the Board of Directors may consider relevant, determine on a quarterly basis the amount of a regular quarterly dividend.
OFLX reports a year-over-year decline in Q4 earnings as declining housing starts weighed on sales volumes, while higher product development and certification costs pressured profitability.
Johnson & Johnson leads Zacks' latest Analyst Blog as new research highlights earnings beats, growth drivers, and risks across major and micro-cap stocks.